research

Announcing Our New Executive Director – Scott Bernstein

September 1st, 2021 MAPS Canada is pleased to announce the appointment of Scott Bernstein as our new Executive Director. A lawyer based in Vancouver, BC, Scott brings over 13 years’ experience in national and international drug policy reform. Prior to joining MAPS Canada, Scott served as Director of Policy for the Canadian Drug Policy Coalition, […]

Announcing Our New Executive Director – Scott Bernstein Read More »

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial

Objective The Center for Psychedelic and Consciousness Research at Johns Hopkins Medical school in Baltimore conducted a randomized, controlled clinical trial to examine if one or two administrations of psilocybin, in addition to psychological support, could be an effective treatment for patients suffering from major depressive disorder (MDD).  What is Major Depressive disorder? Major depressive

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial Read More »